Ticker
WGS
Analysis
Genedx Holdings Corp. (WGS) Stock Analysis
Genedx Holdings Corp. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to WGS.
Genedx Holdings Corp.
Genedx Holdings Corp. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to WGS.
Stock profile
Asset type
Stock
Market cap
$1.75B
Sector
Health Services
Industry
Medical/Nursing Services
Currency
USD
Ticker listings
Genedx Holdings Corp. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
- WGS primary listing
Latest Genedx Holdings Corp. news
GeneDx to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
GAITHERSBURG, Md., May 26, 2026--GeneDx (Nasdaq: WGS) today announced that management will participate in the Goldman Sachs Healthcare Conference from June 8-10 in Miami, FL.
GeneDx Reports First Quarter 2026 Financial Results and Updates Full-Year Outlook
GAITHERSBURG, Md., May 04, 2026--GeneDx reported first quarter financial results and business highlights, including 34% year-over-year volume growth in exome and genome testing.
GeneDx to Report First Quarter 2026 Financial Results on Monday, May 4, 2026
GAITHERSBURG, Md.--(BUSINESS WIRE)-- GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today
Landmark Study Shows Average Cost Savings of $80,000 Per Child and Overall Improved Health Outcomes Following GeneDx Exome and Genome Tes...
GAITHERSBURG, Md., March 11, 2026--Landmark Study Shows Average Cost Savings of $80,000 Per Child and Overall Improved Health Outcomes Following GeneDx Exome and Genome Testing
GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C
Program to expand access to exome sequencing to help clinicians confirm diagnosis and guide clinical decision-making in NPC GAITHERSBURG, Md.--(BUSINESS
Research sections
Valuation
Review valuation context for Genedx Holdings Corp..
Future growth
Review future growth context for Genedx Holdings Corp..
Past performance
Review past performance context for Genedx Holdings Corp..
Financial health
Review financial health context for Genedx Holdings Corp..
Dividend
Review dividend context for Genedx Holdings Corp..
Management
Review management context for Genedx Holdings Corp..
Ownership
Review ownership context for Genedx Holdings Corp..
Other information
Review other information context for Genedx Holdings Corp..
Community
Review community context for Genedx Holdings Corp..